USPTO serial 99501527
HALOZYME HYPERCON
Reviewed by CopyMark Law Group
Status 653
- Filing date
- Status date
- Registration date
- —
- Examiner
- NEWKIRK, MERIDITH E.
- Law office
- TMO LAW OFFICE 111
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with HALOZYME HYPERCON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
San Diego, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gene K. Park
Gene K. Park Morgan, Lewis & Bockius LLPOne Market, Spear Street TowerSan Francisco, CA 94105United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 040 | Custom manufacture of reformulated pharmaceuticals for easier patient delivery; Custom manufacturing of therapeutic molecules of others in the nature of biological and chemical formulations for pharmaceuticals and drugs for others; Processing and treatment of therapeutic chemical and biological materials for phamaceuticals and drugs for others; Biomanufacturing for others, namely, manufacturing therapeutic molecules used in pharmaceuticals and medicine for others using biological organisms in the manufacturing process; Custom manufacture of reformulated pharmaceuticals and therapeutics in the nature of medicine | ACTIVE | — |
| 042 | Research and development in the field of pharmaceuticals and drug delivery; scientific and medical research, namely, conducting clinical trials for others; Scientific research and design and development, namely, product design and development in the field of excipients and biological and chemical formulations for use with therapeutic biologics; Scientific research and design and development in the field of therapeutics in the nature of medicine; Consulting in the fields of product design and development in the field of therapeutic drug formulation and excipient development; Chemical engineering in the nature of formulation and reformulation of therapeutic compositions; Development of new technology for others in the field of biomaterials, biotechnology and nanotechnology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 28, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 28, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 28, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 30, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 30, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 30, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 1, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jul 1, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Apr 2, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 2, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 2, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 25, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 12, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 17, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 17, 2025 | NWAP | NEW APPLICATION ENTERED | — |